|
Jul 28
|
Bristol Myers, Bain Capital form new company to develop immunology drugs
|
|
Jul 28
|
Bristol Myers Squibb and Bain Capital Form New Immunology Company
|
|
Jul 28
|
Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immunology Therapies that Address the Unmet Medical Needs of Patients
|
|
Jul 28
|
Healthcare Earnings Are Coming. 4 Big Questions for CVS, Humana, Merck, UnitedHealth, and More.
|
|
Jul 28
|
Vascarta Announces Addition of Dr. Janet Loesberg to Leadership Team
|
|
Jul 28
|
Will These 5 Pharma/Biotech Bigwigs Surpass Q2 Earnings Forecasts?
|
|
Jul 28
|
Krystal Biotech, Inc. (KRYS) to Report Q2 Results: Wall Street Expects Earnings Growth
|
|
Jul 28
|
Should You Buy, Hold, or Sell BMY Stock Ahead of Q2 Earnings?
|
|
Jul 28
|
Goldman Sachs Maintains a Hold on Bristol-Myers Squibb (BMY)
|
|
Jul 25
|
Biotech Is Booming, and This Undervalued REIT Stands to Gain
|
|
Jul 25
|
Myeloproliferative Disorder Treatment Market Insights, Competitive Landscape, and Forecast Report 2025-2032 Featuring Novartis, Incyte, Bristol Myers Squibb, CTI BioPharma, GSK, PharmaEssentia
|
|
Jul 25
|
Stocks to watch next week: Microsoft, Apple, Shell, AstraZeneca and HSBC
|
|
Jul 25
|
Bristol Myers shuffles its executive ranks with new CMO
|
|
Jul 25
|
Cristian Massacesi, M.D., Joins Bristol Myers Squibb as Executive Vice President, Chief Medical Officer and Head of Development
|
|
Jul 25
|
2 Cash-Producing Stocks to Keep an Eye On and 1 We Find Risky
|
|
Jul 24
|
Roche Weighs Selling Drugs Directly to Patients in Bid to Lower U.S. Prices
|
|
Jul 24
|
Bristol Myers Gains 6.3% in a Month: Buy, Sell or Hold the Stock?
|
|
Jul 24
|
Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for
|
|
Jul 24
|
Bausch Health Announces the Appointment of Two New Members to Its Board of Directors
|
|
Jul 24
|
ModelOp Transforms Enterprise AI Governance with Launch of the First Agentic AI Chat Interface and Controls for Agentic AI
|